Ocumension Therapeutics (FRA:5DG) Price-to-Tangible-Book : 2.45 (As of May. 10, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Ocumension Therapeutics Price-to-Tangible-Book?

As of today (2024-05-10), Ocumension Therapeutics's share price is €0.81. Ocumension Therapeutics's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was €0.33. Hence, Ocumension Therapeutics's Price to Tangible Book Ratio of today is 2.45.

The historical rank and industry rank for Ocumension Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

FRA:5DG' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.37 Med: 3.64 Max: 5.82
Current: 2.45

During the past 6 years, Ocumension Therapeutics's highest Price to Tangible Book Ratio was 5.82. The lowest was 2.37. And the median was 3.64.

FRA:5DG's Price-to-Tangible-Book is ranked better than
56.34% of 1223 companies
in the Biotechnology industry
Industry Median: 2.75 vs FRA:5DG: 2.45

A closely related ratio is called PB Ratio. As of today, Ocumension Therapeutics's share price is €0.81. Ocumension Therapeutics's Book Value per Sharefor the quarter that ended in Dec. 2023 was €0.54. Hence, Ocumension Therapeutics's P/B Ratio of today is 1.49.

Ocumension Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Ocumension Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumension Therapeutics Price-to-Tangible-Book Chart

Ocumension Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

5.56

3.76

3.11

2.27

Ocumension Therapeutics Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial						3.76	3.47	3.11	2.68	2.27

Competitive Comparison of Ocumension Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Ocumension Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocumension Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocumension Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Ocumension Therapeutics's Price-to-Tangible-Book falls into.

Ocumension Therapeutics Price-to-Tangible-Book Calculation

Ocumension Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.81	/	0.331
	=	2.45

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Ocumension Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Ocumension Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocumension Therapeutics (FRA:5DG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocumension Therapeutics (FRA:5DG) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

01477:Hong Kong

Address

No. 1858 Yinzhongnan Road, Guoxiang Subdistrict, Wuzhong District, Suzhou, Jiangsu, CHN

Website

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.

Ocumension Therapeutics (FRA:5DG) Headlines

No Headlines